[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cephalosporin Drugs Market Size study, by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), by Prescription Type (Prescription Drugs and OTC Drugs), and Regional Forecasts 2021-2027

July 2021 | 200 pages | ID: GBADEB3A166CEN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global cephalosporin drugs market is valued approximately at $14.1 billion in 2020 and is anticipated to grow with a healthy growth rate of about 2.6% over the forecast period 2021-2027. Cephalosporin drugs refer to a group of semi-synthetic and wide-spectrum antibiotics which are majorly used in the treatment of bacterial infections such as kidney infections, pneumonia, meningitis, bone infections, sexually transmitted diseases (STDs), etc. The global cephalosporin drugs market is being driven by growing prevalence of infectious diseases and rising demand for anti-microbials in various indications. Furthermore, increase in research and development activities for the development of efficient and safe drugs will provide new opportunities for the global cephalosporin drugs industry. For instance, according to the American Association for the Advancement of Science, in 2021, a research team at the University of Texas had developed chemical probes for the identification of an enzyme which is produced by pneumococcal bacteriaand E. coli bacteria. The research also examined nutritional immunity which comes from the proteins produced by the human body in response to an infection. Also, in 2020, researchers from the University of Hong Kong discovered that infections caused by multidrug resistant superbugs (including pneumonia, bloodstream infections, wound infections, etc.) can be treated by reprocessing antirheumatic gold drug. Such research and development activities are expected to enhance the development of more efficient cephalosporin drugs to treat different bacterial infections and is expected to drive the market growth during the forecast period. However, side effects associated with cephalosporin may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global cephalosporin drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is the leading region across the world in terms of market share and is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027due to factors such as easy availability of cephalosporin drugs, increased consumption of cephalosporin, increase in bacterial infection, rise in over-the-counter drugs sale, etc. in the region.

Major market player included in this report are:
Baxter International
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Lupin Pharmaceuticals Inc.
Macleods Pharmaceuticals Ltd
Mankind Pharma
Merck & Co. Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
Bristol-Myers Squibb Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Generation:
First-Generation Cephalosporin
Second-Generation Cephalosporin
Third-Generation Cephalosporin
Fourth-Generation Cephalosporin
Fifth-Generation Cephalosporin
By Prescription Type:
Prescription Drugs
OTC Drugs
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Cephalosporin Drugs Marketin Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
  1.2.1. Cephalosporin Drugs Market, by Region, 2019-2027 (USD Billion)
  1.2.2. Cephalosporin Drugs Market, by Generation, 2019-2027 (USD Billion)
  1.2.3. Cephalosporin Drugs Market, by Prescription Type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL CEPHALOSPORIN DRUGS MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL CEPHALOSPORIN DRUGS MARKET DYNAMICS

3.1. Cephalosporin Drugs Market Impact Analysis (2019-2027)
  3.1.1. Market Drivers
    3.1.1.1. Growing prevalence of infectious diseases
    3.1.1.2. Rising demand for anti-microbials in various indications
  3.1.2. Market Restraint
    3.1.2.1. Side effects associated with cephalosporin
  3.1.3. Market Opportunities
    3.1.3.1. Increase in R&D activities for the development of efficient and safe drugs

CHAPTER 4. GLOBAL CEPHALOSPORIN DRUGS MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL CEPHALOSPORIN DRUGS MARKET, BY GENERATION

a. Market Snapshot
5.1. Global Cephalosporin Drugs Market by Generation, , Performance - Potential Analysis
5.2. Global Cephalosporin Drugs Market Estimates & Forecasts by Generation, 2018-2027 (USD Billion)
5.3. Cephalosporin Drugs Market, Sub Segment Analysis
  5.3.1. First-Generation Cephalosporin
  5.3.2. Second-Generation Cephalosporin
  5.3.3. Third-Generation Cephalosporin
  5.3.4. Fourth-Generation Cephalosporin
  5.3.5. Fifth-Generation Cephalosporin

CHAPTER 6. GLOBAL CEPHALOSPORIN DRUGS MARKET, BY PRESCRIPTION TYPE

6.1. Market Snapshot
6.2. Global Cephalosporin Drugs Market by Prescription Type, Performance - Potential Analysis
6.3. Global Cephalosporin Drugs Market Estimates & Forecasts by Prescription Type2018-2027 (USD Billion)
6.4. Cephalosporin Drugs Market, Sub Segment Analysis
  6.4.1. Prescription Drugs
  6.4.2. OTC Drugs

CHAPTER 7. GLOBAL CEPHALOSPORIN DRUGS MARKET, REGIONAL ANALYSIS

7.1. Cephalosporin Drugs Market, Regional Market Snapshot
7.2. North America Cephalosporin Drugs Market
  7.2.1. U.S. Cephalosporin Drugs Market
    7.2.1.1. Generation breakdown estimates & forecasts, 2018-2027
    7.2.1.2. Prescription Type breakdown estimates & forecasts, 2018-2027
  7.2.2. Canada Cephalosporin Drugs Market
7.3. Europe Cephalosporin Drugs Market Snapshot
  7.3.1. U.K. Cephalosporin Drugs Market
  7.3.2. Germany Cephalosporin Drugs Market
  7.3.3. France Cephalosporin Drugs Market
  7.3.4. Spain Cephalosporin Drugs Market
  7.3.5. Italy Cephalosporin Drugs Market
  7.3.6. Rest of Europe Cephalosporin Drugs Market
7.4. Asia-Pacific Cephalosporin Drugs Market Snapshot
  7.4.1. China Cephalosporin Drugs Market
  7.4.2. India Cephalosporin Drugs Market
  7.4.3. Japan Cephalosporin Drugs Market
  7.4.4. Australia Cephalosporin Drugs Market
  7.4.5. South Korea Cephalosporin Drugs Market
  7.4.6. Rest of Asia Pacific Cephalosporin Drugs Market
7.5. Latin America Cephalosporin Drugs Market Snapshot
  7.5.1. Brazil Cephalosporin Drugs Market
  7.5.2. Mexico Cephalosporin Drugs Market
7.6. Rest of The World Cephalosporin Drugs Market

CHAPTER 8. COMPETITIVE INTELLIGENCE

8.1. Top Market Strategies
8.2. Company Profiles
  8.2.1. Baxter International
    8.2.1.1. Key Information
    8.2.1.2. Overview
    8.2.1.3. Financial (Subject to Data Availability)
    8.2.1.4. Product Summary
    8.2.1.5. Recent Developments
  8.2.2. F. Hoffmann-La Roche Ltd
  8.2.3. GlaxoSmithKline PLC
  8.2.4. Lupin Pharmaceuticals Inc.
  8.2.5. Macleods Pharmaceuticals Ltd
  8.2.6. Mankind Pharma
  8.2.7. Merck & Co. Inc.
  8.2.8. Pfizer Inc.
  8.2.9. Teva Pharmaceutical Industries Ltd
  8.2.10. Bristol-Myers Squibb Company

CHAPTER 9. RESEARCH PROCESS

9.1. Research Process
  9.1.1. Data Mining
  9.1.2. Analysis
  9.1.3. Market Estimation
  9.1.4. Validation
  9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES

TABLE 2. Global Cephalosporin Drugs Market, report scope
TABLE 3. Global Cephalosporin Drugs Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Cephalosporin Drugs Market estimates & forecasts by Generation 2018-2027 (USD Billion)
TABLE 5. Global Cephalosporin Drugs Market estimates & forecasts by Prescription Type 2018-2027 (USD Billion)
TABLE 6. Global Cephalosporin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Cephalosporin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Cephalosporin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Cephalosporin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Cephalosporin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Cephalosporin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Cephalosporin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Cephalosporin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Cephalosporin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Cephalosporin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Cephalosporin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Cephalosporin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Cephalosporin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Cephalosporin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Cephalosporin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Cephalosporin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. U.S. Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Canada Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Canada Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Canada Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. UK Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. UK Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. UK Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. Germany Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. Germany Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. Germany Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. France Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. France Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. France Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Spain Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Spain Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Spain Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Italy Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. Italy Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. Italy Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. ROE Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. ROE Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. ROE Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. China Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. China Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. China Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. India Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. India Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. India Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Japan Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Japan Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Japan Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Australia Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 56. Australia Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. Australia Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. South Korea Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 59. South Korea Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. South Korea Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. ROPAC Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 62. ROPAC Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. ROPAC Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. Brazil Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 65. Brazil Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Brazil Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Mexico Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 68. Mexico Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. Mexico Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. ROLA Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 71. ROLA Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROLA Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROW Cephalosporin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 74. ROW Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. ROW Cephalosporin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. List of secondary sources used in the study of global Cephalosporin Drugs Market.
TABLE 77. List of primary sources used in the study of global Cephalosporin Drugs Market.
TABLE 78. Years considered for the study.
TABLE 79. Exchange rates considered.
LIST OF FIGURES

FIG 1. Global Cephalosporin Drugs Market, research methodology
FIG 2. Global Cephalosporin Drugs Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Cephalosporin Drugs Market, key trends 2020
FIG 5. Global Cephalosporin Drugs Market, growth prospects 2021-2027
FIG 6. Global Cephalosporin Drugs Market, porters 5 force model
FIG 7. Global Cephalosporin Drugs Market, pest analysis
FIG 8. Global Cephalosporin Drugs Market, value chain analysis
FIG 9. Global Cephalosporin Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Cephalosporin Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Cephalosporin Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Cephalosporin Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Cephalosporin Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Cephalosporin Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Cephalosporin Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Cephalosporin Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Cephalosporin Drugs Market, regional snapshot 2018 & 2027
FIG 18. North America Cephalosporin Drugs Market2018 & 2027 (USD Billion)
FIG 19. Europe Cephalosporin Drugs Market2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Cephalosporin Drugs Market2018 & 2027 (USD Billion)
FIG 21. Latin America Cephalosporin Drugs Market2018 & 2027 (USD Billion)
FIG 22. Global Cephalosporin Drugs Market, company market share analysis (2020)


More Publications